Find Your MAC! Add TransLabs as a preferred
source on Google
Palmetto GBA Technical Assessment

Palmetto GBA Technical Assessment Survival Guide: Getting Genetic Sequencing Approved in Georgia

Georgia laboratories billing Medicare for genetic sequencing must follow Palmetto GBA’s MolDX requirements before submitting claims under Jurisdiction J. Unlike commercial prior authorization, the MolDX Technical Assessment evaluates the laboratory test itself and requires supporting evidence of analytical validity, clinical validity, and clinical utility. Approved tests receive a unique DEX Z-Code that must be correctly linked to the claim and supported by applicable Medicare coverage policies.

However, Z-Code approval alone does not guarantee payment; the patient’s diagnosis and testing circumstances must also align with current LCD and Local Coverage Article requirements. For Georgia labs offering NGS panels, germline testing, or other molecular diagnostics, accurate Technical Assessment documentation, current coding rules, and front-end claim validation can help prevent systemic denials and protect Medicare revenue.

If your laboratory bills Medicare patients in Georgia, you already know that getting paid for genetic sequencing isn’t an easy task. The rules are strict, the systems are automated, and a single misstep can trigger a cascade of denials before a human reviewer ever looks at your claim.

Under Palmetto GBA, the Medicare Administrative Contractor (MAC) for Jurisdiction J, genetic tests don’t go through a standard prior authorization. Instead, they run through the Molecular Diagnostic Services (MolDX) program, which has its own rigorous Technical Assessment (TA) process, registry, and unique identifiers called DEX Z-Codes.

This guide breaks down exactly what your revenue cycle management (RCM) team needs to know in 2026: how the TA process works, which forms to use, how to build clean claims, and how to keep automated denials off your AR aging report. We’ll also discuss how expert laboratory billing services in Georgia help with all that.

Get Palmetto GBA Claims in Georgia Reimbursed with Technical Assessment Compliant Billing.

Palmetto GBA MolDX: What Georgia Labs Must Know in 2026

The MolDX program is the coverage and payment framework that governs molecular diagnostic tests (MDTs) for Medicare patients under Palmetto GBA. It applies to labs in states across Jurisdiction J (Alabama, Georgia, and Tennessee), among other jurisdictions. But many Georgia labs, especially those running next-generation sequencing (NGS) panels, experience claim denials because they don’t fully understand how MolDX works.

Here’s the core thing to understand: MolDX replaces traditional prior authorization. Commercial payers like Anthem BCBS or Ambetter require a patient-specific pre-auth before you run a test. Palmetto GBA doesn’t work that way. Instead, your lab must get the test itself approved before you can ever bill it to Medicare, regardless of the patient.

That’s a big deal. It means the denial is systematic. And fixing it requires understanding the full pipeline from test registration to claim submission.

MolDX vs. Commercial Prior Authorization: Clearing Up the Confusion

One of the most common billing mistakes labs make is treating a Medicare molecular claim exactly like a commercial claim. That approach will cost you. Here’s a side-by-side comparison that puts it plainly:
FeatureCommercial Prior AuthorizationPalmetto GBA MolDX Technical Assessment
Approval LevelPer patient, per episode of carePer laboratory test (one-time approval)
Submission TimingBefore the test is performedBefore the test is ever marketed or billed
Identifier UsedAuthorization number (e.g., from AIM/Carelon)DEX Z-Code appended to the claim
Core DocumentationPatient chart notes, medical necessity for that patientValidation dossier covering analytical and clinical validity, plus clinical utility
RCM Impact of FailureOne patient's claim was denied (preventable with pre-auth)Every single claim for that CPT code gets auto-rejected
See the difference? A missed commercial pre-auth hurts just one claim. But a missing Z-Code affects your entire billing pipeline for that test. That’s why getting the technical assessment right the first time is so critical.

The Three Pillars of the MolDX Technical Assessment

So what does Palmetto GBA actually want to see in your TA dossier? Under LCD L35025 (MolDX: Molecular Diagnostic Tests), any test that identifies nucleic acids (DNA/RNA), proteins, or chromosomes must satisfy three evidence-based criteria to be deemed “reasonable and necessary” under Social Security Act § 1862(a)(1)(A).

Analytical Validity (AV)

This is about your assay’s technical performance. Can your test accurately and reproducibly detect the specific genetic variants (SNVs, INDELs, copy number alterations, fusions) it’s supposed to find within your stated limit of detection? If the answer is yes and you can prove it with internal validation data, you’ve cleared the first hurdle.

Clinical Validity (CV)

Passing analytical validity isn’t enough. You also have to show that the variants your assay detects are genuinely associated with the target clinical condition. This means peer-reviewed literature, population studies, or clinical trial data establishing a reliable link between the biomarkers and the disease state.

Clinical Utility (CU)

This is the hardest pillar to clear. It’s where most dossiers fall apart. Clinical utility means your test doesn’t just find something; it changes what the physician does. Does it match the patient to an FDA-approved targeted therapy? Does it rule out an unnecessary intervention?

If the results sit in a chart and never alter the clinical path, the test lacks utility in MolDX’s eyes, and it won’t get approved. All three pillars must be addressed before Palmetto GBA will issue a DEX Z-Code.

The DEX Diagnostics Exchange: Your Registration Starting Point

Submit your Technical Assessment through the DEX Diagnostics Exchange (DEX), the official registry mandated by Palmetto GBA for all MolDX test registrations.

Here’s the basic process:

  1. Register your laboratory entity on the DEX main portal if you haven’t already.
  2. Log in to the secure registry application at the DEX Z-Code website to initiate a new test registration.
  3. Select the correct TA worksheet for your test type and complete it in full.
  4. Compile your full dossier, including your validation data, peer-reviewed references, and all required supporting documents.
  5. Submit through DEX and await technical review. Complex NGS panels can take up to 60 days to process.
  6. Receive your 5-character alphanumeric DEX Z-Code upon approval and map it immediately into your billing system.

If your lab sends specimens to a reference laboratory, you’ll also need to set up a Z-Code sharing agreement through the DEX portal. Without that agreement in place, even a fully approved test can trigger a denial because the billing lab doesn’t have authorization to use the Z-Code.

2026 TA Worksheets by Test Category: Which Form Does Your Lab Need?

Palmetto GBA doesn’t accept a one-size-fits-all validation summary. Each test type has a specific, structured worksheet, and submitting the wrong form is an instant denial.

Here’s a quick-reference guide by test type:

Test CategoryApplicable LCDRequired TA Form
Solid Tumor NGS (hot-spot and CGP panels)LCD L38045SOM-PF-004
Myeloid and Hematopoietic Malignancies (AML, MDS, MPN)LCD L38047SOM-PF-005
Inherited Cancer Testing (germline)Germline testing guidelinesGER-PF-006
Inherited Germline Testing (non-cancer)Germline testing guidelinesGER-PF-008
Pharmacogenomics (PGx)PGx coverage policyPGX-PF-007
Minimal Residual Disease (MRD)MRD coverage policyMRD-PF-016
Molecular Risk StratificationMRS coverage policyMRS-PF-020
Syndromic Infectious Disease PanelsInfectious disease MDT policyMID-PF-019
Solid Organ Allograft RejectionAllograft policyALLO-CQ-003 + ALLO-PF-009

Important note: Always download worksheets directly from Palmetto GBA’s portal before submitting. Forms are updated periodically, and using an outdated version, even by a quarter, can trigger an automatic administrative denial. Also check DEX Official Forms Checklist and Matrix, a useful companion tool that maps each test methodology to the correct somatic or germline form.

LCD and LCA Alignment: The Hidden Cause of Most Post-Approval Denials

Here’s something labs often miss: getting a DEX Z-Code doesn’t mean every claim gets automatically reimbursed. That Z-Code just helps your claim pass through the first step. Once your claim is in adjudication, Palmetto GBA’s system checks it against Local Coverage Determinations (LCDs) and Local Coverage Articles (LCAs) to confirm that the patient’s diagnosis supports medical necessity for that specific test.

The most important billing reference document is LCA A56853 (Billing and Coding: MolDX: Molecular Diagnostic Tests). This article maps:

  • CPT codes
  • Approved modifiers
  • Clinical instructions required for claim approval

If you’re billing CPT 81445 (solid tumor NGS) but submitting an ICD-10 code that isn’t listed in the active LCA for that CPT, your claim is automatically denied for medical necessity, even with a valid Z-Code attached.

The Most Common LCD/LCA Misalignment Errors

  • ICD-10 codes not included in the LCA diagnostic list: Palmetto GBA’s LCAs contain very specific diagnosis codes. A cancer diagnosis that seems clinically obvious may not appear on the list.
  • Cancer severity not meeting LCD criteria: Under LCD L38045, solid tumor NGS is generally covered for advanced, recurrent, or metastatic cancers. Early-stage diagnoses often don’t qualify.
  • Myeloid malignancy timing issues: LCD L38047 covers cytopenias of undetermined significance lasting more than four months. Billing too early triggers a denial.
  • Outdated ICD-10 lists in your LIS or PMS: Palmetto GBA updates its LCAs multiple times per year. If your practice management system (PMS) hasn’t been refreshed, your billers are working with stale rules.

The fix? Monitor the CMS Medicare Coverage Database (MCD) regularly, or at least every month, for any updates to active LCDs and LCAs that govern your test menu.

How to Build a Clean Claim: DEX Z-Code Placement on 837 and CMS-1500

You’ve got your Z-Code. Your ICD-10 codes are aligned. Now comes the part that trips up even experienced billers: putting the Z-Code in exactly the right place on the claim.

Palmetto GBA’s adjudication system is fully automated, which means placement matters as much as the code itself. A Z-Code in the wrong field is just as bad as a missing one.

Whether you submit claims in-house or outsource claim submission to a reliable billing partner, such as TransLabs, you must master the use of DEX Z-Code on your lab claims for correct claims and secured reimbursement.

Electronic Claims (837P / 837I)

  • Report the Z-Code in Loop 2400, Segment SV101-7, the product/service ID qualifier field on the claim line, immediately alongside the CPT code.
  • Some clearinghouses may route it differently. Always consult your clearinghouse’s 2026 companion guide before making assumptions about field mapping.
  • For 837I (institutional) claims, equivalent placement is the SV202-7 segment.

Paper Claims (CMS-1500)

  • Enter the Z-Code in the shaded area of Box 24A (above the date of service line), or in Box 19 as a standard narrative.
  • Formatting must be exact: DEX Z-CODE: XXXXX, replacing XXXXX with your unique five-character code.

Billing Unlisted CPT Code 81479

Many proprietary genetic panels don’t map neatly to a standard CPT code. These get billed under the unlisted molecular pathology code 81479. Since unlisted codes require manual review, attaching a pre-approved Z-Code to the claim gives the reviewer an instant reference point for what the test is and what fee schedule applies, cutting AR days from 90-plus down to under 15 in many cases.

RCM Automation Strategies to Prevent Systemic Denials

Let’s be real: manually tracking every LCD update, every Z-Code expiration, and every ICD-10 list revision across multiple test panels is not sustainable. Georgia labs running high volumes of NGS claims need automated safeguards baked into their revenue cycle.
Reduce Denials For Your Genetic Sequencing Claims with Expert Billing Support in Georgia.

Front-End Z-Code Scrubbers

Implement a scrubbing rule in your clearinghouse engine that halts any molecular pathology CPT code (81400 to 81479) submitted for a Georgia Medicare patient if the matching Z-Code is missing from the SV101-7 segment. This catches the error before the claim ever reaches Palmetto GBA’s system.

Dynamic LCD/LCA Monitoring

Set up RCM automation to query the CMS Medicare Coverage Database every week. When Palmetto GBA updates its LCA diagnostic lists, which happens multiple times a year, your system should automatically update medical necessity rules into your laboratory information system (LIS) and PMS before the payer denies your claim.

Automated Z-Code to CPT Cross-Referencing

AI-driven claim scrubbers can cross-reference the ordered genetic panel against the DEX registry and the patient’s Jurisdiction J Medicare status, automatically inserting the correct Z-Code into the claim before submission. This eliminates human error at the point of claim generation.

Z-Code Sharing Agreement Verification

If you’re a send-out lab or a billing lab for a reference laboratory, your RCM workflow should include an automated check confirming that an active Z-Code sharing agreement is in place through the DEX registry before the claim is submitted. Expired or missing agreements are a leading cause of otherwise-clean claims being denied.

Conclusion

Billing genetic sequencing to Medicare in Georgia isn’t complicated once you understand how the system is actually built. The MolDX Technical Assessment isn’t a hurdle. It’s the foundation. Get it right, and your claims flow cleanly. Skip a step or use the wrong form, and your entire billing pipeline for that test shuts down automatically.

The key takeaways are simple:

  • MolDX replaces commercial prior authorization. Your test needs approval, not your patient.
  • Submit through the DEX portal with the correct specialty-specific worksheet.
  • Place your Z-Code in the exact right field on electronic and paper claims.
  • Keep your ICD-10 diagnosis codes in sync with the active LCAs and automate that process wherever you can.

If your lab is running NGS panels, pharmacogenomics tests, or germline sequencing for Georgia Medicare patients and you’re still dealing with high denial rates, it’s time to fix your front-end process, whether it’s in your TA documentation or your claim-building workflow. Getting that front-end process right is what turns a struggling billing department into one that consistently collects what it earns.

Frequently Asked Questions

What is a DEX Z-Code and why does my lab need one?

A DEX Z-Code is a unique five-character identifier assigned after Palmetto GBA approves your Technical Assessment dossier. Without it, every Medicare claim for that test is rejected at the front-end edit, before a human ever sees it. It’s your entry ticket to adjudication under MolDX.
Simpler assays may finish in 30 days or less. Complex next-generation sequencing panels, like comprehensive genomic profiling, can take up to 60 days. Don’t bill Medicare until your Z-Code is in hand and mapped in your billing system.
You can’t bill Medicare for a genetic test until your Technical Assessment is under review. Your TA must be fully approved, and your Z-Code should be active before you perform or bill the test. Submitting claims before approval is not just a denial risk; it’s a compliance violation. Hold claims until DEX registration is complete.
Use form SOM-PF-004, the Analytical and Clinical Validation Summary Worksheet for Solid Tumors. It captures gene lists, fusion detection, and TMB methodology. Always grab the latest version directly from the Palmetto GBA MolDX Forms Portal before submitting. They’re updated regularly.
A Z-Code clears the front-end edit, but payment still requires meeting medical necessity criteria in the active Local Coverage Article. The most common culprit is an ICD-10 diagnosis code that’s not on the LCA’s covered list. Check LCA A56853 and the matching LCD to confirm your codes align exactly.
You need a separate Z-Code agreement if your lab is the billing entity sending tests to a performing reference lab. You need an active sharing agreement set up through the DEX portal; otherwise, you aren’t authorized to use that lab’s Z-Code on the claim.

Your Trusted Lab Billing Partner

Book Your Free Consultation

Book Consultation Today!

Book Consultation Today!